RARG (Retinoic Acid Receptor Gamma)

Nuclear receptor involved in development, differentiation, and cancer

Gene Information Card

Symbol RARG
Full Name Retinoic Acid Receptor Gamma
Gene Type protein-coding
Chromosomal Location 12q13.13
NCBI Gene ID 5916 ncbi.nlm.nih.gov/gene/5916
Ensembl ID ENSG00000172819
UniProt ID P13631
OMIM ID 180190
HGNC ID 9866
Aliases RARC, NR1B3, retinoic acid receptor gamma

Description

The RARG gene encodes retinoic acid receptor gamma, a nuclear receptor that functions as a ligand-dependent transcription factor. It binds retinoic acid and regulates gene expression involved in cell differentiation, proliferation, and embryonic development. RARG is part of the retinoic acid receptor family and forms heterodimers with retinoid X receptors to modulate target gene transcription.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Acute Promyelocytic Leukemia (APL) RARG rearrangements (e.g., PML-RARG) disrupt retinoic acid signaling, blocking differentiation PMID: 29276051
Acute Myeloid Leukemia (AML) RARG mutations and fusions contribute to leukemogenesis via altered transcriptional regulation COSMIC ID: 1005
Retinoic Acid Resistance RARG mutations in cancer cells reduce sensitivity to retinoid therapy ClinVar: RARG-related

Expression Profile

Tissue Expression
Tissue nTPM level
Skin 12.5 Medium
Adipose Tissue 8.3 Low
Liver 6.1 Low
Bone Marrow 4.2 Low
Testis 3.8 Low
Cell Line Expression
Cell Line nTPM Notes
HL-60 (leukemia) 5.0 Promyelocytic cell line
MCF7 (breast cancer) 3.2 Epithelial cell line
A549 (lung cancer) 2.1 Epithelial cell line
K562 (leukemia) 1.5 Myelogenous leukemia line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
p.Arg394Trp Missense <0.1% Altered ligand binding and transactivation
p.Leu398Pro Missense <0.1% Reduced retinoic acid response
PML-RARG fusion Chromosomal rearrangement Rare Oncogenic fusion in APL
c.1150C>T Nonsense <0.1% Premature truncation, loss of function
Mutation functional classification

Loss of Function (LOF)

Missense and nonsense mutations impair DNA binding or ligand activation, reducing transcriptional activity.

Gain of Function (GOF)

Fusion proteins like PML-RARG can aberrantly activate or repress target genes, promoting leukemogenesis.

Dominant Negative (DN)

Some RARG mutants interfere with wild-type receptor function, blocking normal differentiation signals.

Pathways

Retinoic acid receptor signaling pathway (Reactome: R-HSA-9006931)
Nuclear receptor transcription pathway (KEGG: hsa03320)
Acute myeloid leukemia (KEGG: hsa05221)

Protein Summary

Retinoic acid receptor gamma (RARG) is a 454-amino-acid nuclear receptor with a DNA-binding domain and a ligand-binding domain. It binds all-trans retinoic acid and 9-cis retinoic acid, regulating genes involved in cell growth and differentiation. RARG is critical for skin, bone, and neural development. Aberrant RARG activity, including fusions with PML, is implicated in acute promyelocytic leukemia and other cancers.

Related Products

Product name Cat.No. Species Gene ID
RARG Knockout HEK293 Cell Line EDJ-KQ3001 Human 5916 Details Get a Quote
TRARG1 Knockout HEK293 Cell Line EDJ-KQ15908 Human 286753 Details Get a Quote
RARG Knockout A-549 Cell Line EDJ-KQ24201 Human 5916 Details Get a Quote
RARG Knockout HeLa Cell Line EDJ-KQ24203 Human 5916 Details Get a Quote
RARG Knockout HCT 116 Cell Line EDJ-KQ22831 Human 5916 Details Get a Quote
TRARG1 Knockout HeLa Cell Line EDJ-KQ59564 Human 286753 Details Get a Quote
TRARG1 Knockout A-549 Cell Line EDJ-KQ68030 Human 286753 Details Get a Quote
TRARG1 Knockout HCT 116 Cell Line EDJ-KQ76410 Human 286753 Details Get a Quote
RARG Knockout HAP1 Cell Line EDC08290 Human 5916 Details Get a Quote
Displaying Records 1 To 9 Of 9 Records
Contact Us
*
*
*
*
How did you hear about us: